Here are relevant reports on : automotive-diagnostics-market
-
Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay (Elisa), Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023
The global neuroscience antibodies and assays market is expected to reach USD 4.18 Billion by 2023, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. The neuroscience antibodies and assays market is fragmented, with the presence of several large as well as emerging players. Some of the the top players in this market are Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad (US), and Merck KGaA (Germany).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
AI in Telecommunication Market by Technology, Application (Network Optimization, Network Security, Self-diagnostics, Customer Analytics, and Virtual Assistance), Component (Solutions and Services), Deployment Mode, and Region - Global Forecast to 2022
The increasing adoption of Artificial Intelligence (AI) for various applications in the telecommunication industry and utilization of AI-enabled smartphones are expected to be driving the growth of the AI in telecommunication market. MarketsandMarkets expects the global AI in telecommunication market to grow from USD 235.7 Million in 2016 to USD 2,497.8 Million by 2022, at a Compound Annual Growth Rate (CAGR) of 46.8% during the forecast period. The base year considered for the study is 2016 and the forecast period is 2017–2022. The AI in telecommunication market report encompasses the competitive landscape and company profiles of the key vendors based on their product offerings and business strategies. The major AI in telecommunication vendors include IBM (US), Microsoft (US), Intel (US), Google (US), AT&T (US), Cisco Systems (US), Nuance Communications (US), Sentient Technologies (US), H2O.ai (US), Infosys (India), Salesforce (US), and NVIDIA (US).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Blood Glucose Monitoring Devices Market by Product [Blood Glucose Meters, Continuous Glucose Monitoring Systems (Sensors, Transmitter), Glucose Monitoring Strips, Lancets], Application (Hospitals, Diagnostics, Home Settings) - Global Forecasts to 2019
The global blood glucose monitoring devices market is expected to grow at a significantly high rate in the next five years. Global rise in the prevalence and incidence of diabetes and increasing adoption of continuous glucose monitoring (CGM) systems are the key factors propelling the growth of this market. In addition, continuous technological advancements in blood glucose monitoring devices and rapid growth in aging population are further stimulating the demand for blood glucose monitoring devices. However, inadequate reimbursement and high cost associated with the application of CGM systems and product recalls are some of the key factors hampering the growth of this market.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Construction & Mining Fleet Management Market by Solution (Operations Management, Battery Maintenance & Diagnostics, Performance Management, Fleet Analytics & Reporting), Fleet Type (Passenger Cabs, Commercial, Public Transport) - Global Forecast to 2030
The construction & mining fleet management market is projected to reach USD 7.28 billion by 2030, growing from USD 4.04 billion in 2025 at a CAGR of 12.5% during the forecast period. The key players include Caterpillar (US), Komatsu (Japan), Volvo (Sweden), Samsara (US), Wenco (Canada), Hexagon (Sweden), Sandvik (Sweden), RPMGlobal (Australia), Verizon Connect (US), Teletrac Navman (US), JCB (UK), Liebherr (Switzerland), CNH Industrial America (US), Geotab (Canada), and Epiroc (Sweden).
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Early Toxicity Testing Market by Technique (In-vivo, In-vitro, & In-Silico), End-user (Pharmaceutical, Diagnostics, Food, Chemicals, Cosmetics, & Others), Trend & Global Forecast to 2019
Toxicity is an extent to which a particular substance can damage the living organism; it is important parameter to be evaluated during all stages of drug development. Toxicity testing is conducted to determine the degree to which a substance can damage a living or non-living organism. Owing to the higher rejection rate of drug in the recent years citing high toxicity level, the companies have started using toxicity testing in drug discovery
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Middle East & Africa In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Infectious Disease) - Forecast to 2031
The Middle East & Africa in vitro diagnostics (IVD) market, valued at USD 3.33 billion in 2025, stood at USD 3.49 billion in 2026 and is projected to advance at a resilient CAGR of 4.8% from 2026 to 2031, culminating in a forecasted valuation of USD 4.42 billion by the end of the period.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Imaging Chemicals Market by Product Type (Printing Inks, Image Developers), Application (Printing & Packaging, Medical Diagnostics, Textile Processing), and Region (North America, Europe, APAC, MEA, and South America) - Global Forecast to 2022
The imaging chemicals market is estimated to grow from USD 22.08 Billion in 2017 to USD 29.97 Billion by 2022, at a CAGR of 6.3% from 2017 to 2022. Imaging chemicals are chemicals substances that used to produce or develop photographs. The imaging chemicals market is segmented by product type, application, and region. Key companies profiled in this research report on the imaging chemicals market include Fujifilm (Japan), The Eastman Kodak Company (US), Vivimed Labs (India), DIC Corp. (Japan), Flint Group (Germany), Sakata Inx (Japan), Toyo Ink SC (Japan), Siegwerk Druckfarben (Germany), and T&K Toka (Japan).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Laboratory Proficiency Testing Market by Industry (Clinical Diagnostics, Microbiology, Pharmaceutical, Food & Animal Feed, Water, Opioid), Technology (PCR, Cell Culture), and Region; Unmet Needs, Stakeholder & Buying Criteria - Global Forecast to 2028
The global laboratory proficiency testing market, valued at US$1.1 billion in 2022, stood at US$1.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.4% from 2023 to 2028, culminating in a forecasted valuation of US$1.6 billion by the end of the period. The proficiency testing market is projected to experience substantial expansion in the forecasted period due to its mandatory requirement for laboratories operating in various regulated industries like APIAC, CLIA, and CLSI.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024
The Lymphedema Diagnostics Market is expected to grow from USD 24 million in 2019 to USD 35 million by 2024, at a CAGR of 7.4% during the forecast period. The major players operating in the lymphedema diagnostics market are GE Healthcare (US), Philips (Netherlands), and Siemens Healthineers (Germany). Other prominent players in this market include Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
DNA Diagnostics Market by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Global Forecast to 2029
The global DNA diagnostics market, valued at US$12.3 billion in 2023, stood at US$13.3 billion in 2024 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2029, culminating in a forecasted valuation of US$21.2 billion by the end of the period. Growth in the market is primarily driven by the technological improvements in the DNA diagnostics industry and the growing need for personalized treatment and early disease diagnosis in developing nations. Also, the increased investments by healthcare-based companies are majorly contributing to growth of the market.
- Published: July 2024
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
